title: Expression, mutation and copy number analysis of platelet-derived growth factor receptor A (PDGFRA) and its ligand PDGFA in gliomas.
abstract: BACKGROUND
  Malignant gliomas are the most prevalent type of primary brain tumours but the therapeutic armamentarium for these tumours is limited. Platelet-derived growth factor (PDGF) signalling has been shown to be a key regulator of glioma development. Clinical trials evaluating the efficacy of anti-PDGFRA therapies on gliomas are ongoing. In this study, we intended to analyse the expression of PDGFA and its receptor PDGFRA, as well as the underlying genetic (mutations and amplification) mechanisms driving their expression in a large series of human gliomas.
  
  
  METHODS
  PDGFA and PDGFRA expression was evaluated by immunohistochemistry in a series of 160 gliomas of distinct World Health Organization (WHO) malignancy grade. PDGFRA-activating gene mutations (exons 12, 18 and 23) were assessed in a subset of 86 cases by PCR-single-strand conformational polymorphism (PCR-SSCP), followed by direct sequencing. PDGFRA gene amplification analysis was performed in 57 cases by quantitative real-time PCR (QPCR) and further validated in a subset of cases by chromogenic in situ hybridisation (CISH) and microarray-based comparative genomic hybridisation (aCGH).
  
  
  RESULTS
  PDGFA and PDGFRA expression was found in 81.2% (130 out of 160) and 29.6% (48 out of 160) of gliomas, respectively. Its expression was significantly correlated with histological type of the tumours; however, no significant association between the expression of the ligand and its receptor was observed. The absence of PDGFA expression was significantly associated with the age of patients and with poor prognosis. Although PDGFRA gene-activating mutations were not found, PDGFRA gene amplification was observed in 21.1% (12 out of 57) of gliomas. No association was found between the presence of PDGFRA gene amplification and expression, excepting for grade II diffuse astrocytomas.
  
  
  CONCLUSIONS
  The concurrent expression of PDGFA and PDGFRA in different subtypes of gliomas, reinforce the recognised significance of this signalling pathway in gliomas. PDGFRA gene amplification rather than gene mutation may be the underlying genetic mechanism driving PDGFRA overexpression in a portion of gliomas. Taken together, our results could provide in the future a molecular basis for PDGFRA-targeted therapies in gliomas.
authors.affiliation: Life and Health Sciences Research Institute, School of Health Sciences, University of Minho, 4710 Braga, Portugal.
authors.forename: O
authors.initials: O
authors.lastname: Martinho
authors.forename: A
authors.initials: A
authors.lastname: Longatto-Filho
authors.forename: M B K
authors.initials: MB
authors.lastname: Lambros
authors.forename: A
authors.initials: A
authors.lastname: Martins
authors.forename: C
authors.initials: C
authors.lastname: Pinheiro
authors.forename: A
authors.initials: A
authors.lastname: Silva
authors.forename: F
authors.initials: F
authors.lastname: Pardal
authors.forename: J
authors.initials: J
authors.lastname: Amorim
authors.forename: A
authors.initials: A
authors.lastname: Mackay
authors.forename: F
authors.initials: F
authors.lastname: Milanezi
authors.forename: N
authors.initials: N
authors.lastname: Tamber
authors.forename: K
authors.initials: K
authors.lastname: Fenwick
authors.forename: A
authors.initials: A
authors.lastname: Ashworth
authors.forename: J S
authors.initials: JS
authors.lastname: Reis-Filho
authors.forename: J M
authors.initials: JM
authors.lastname: Lopes
authors.forename: R M
authors.initials: RM
authors.lastname: Reis
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D001932:Brain Neoplasms / Q000737:chemistry* / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D005260:Female; D005784:Gene Amplification; D018628:Gene Dosage; D005910:Glioma / Q000737:chemistry* / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D010982:Platelet-Derived Growth Factor / Q000032:analysis* / Q000235:genetics; D020796:Receptor, Platelet-Derived Growth Factor alpha / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000235:genetics; D015398:Signal Transduction
chemical_list: D010982:Platelet-Derived Growth Factor; C075278:platelet-derived growth factor A; D020796:Receptor, Platelet-Derived Growth Factor alpha
references.citation: Neuro Oncol. 2008 Jun;10(3):330-40
references.pmid: 18359865
references.citation: Cancer Cell. 2003 May;3(5):439-43
references.pmid: 12781361
references.citation: Genes Chromosomes Cancer. 2008 Aug;47(8):697-711
references.pmid: 18484635
references.citation: Lab Invest. 2008 May;88(5):491-503
references.pmid: 18332872
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20007-12
references.pmid: 18077431
references.citation: J Clin Invest. 1990 Jul;86(1):131-40
references.pmid: 2164040
references.citation: J Cell Physiol. 2006 Jul;208(1):220-8
references.pmid: 16575905
references.citation: Clin Cancer Res. 2008 Jun 1;14(11):3386-94
references.pmid: 18519768
references.citation: Glia. 1995 Nov;15(3):257-63
references.pmid: 8586462
references.citation: Neurosurgery. 1998 Feb;42(2):341-6
references.pmid: 9482185
references.citation: J Neurooncol. 2008 Jan;86(2):183-90
references.pmid: 17690840
references.citation: Cancer Res. 1998 Dec 1;58(23):5275-9
references.pmid: 9850047
references.citation: Genomics. 2007 May;89(5):647-53
references.pmid: 17276656
references.citation: J Pathol. 2008 Aug;215(4):398-410
references.pmid: 18484683
references.citation: J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):782-7
references.pmid: 12023424
references.citation: J Clin Oncol. 2005 Jan 1;23(1):49-57
references.pmid: 15545668
references.citation: J Neurosurg. 1991 Sep;75(3):447-51
references.pmid: 1651380
references.citation: Nat Rev Cancer. 2004 May;4(5):361-70
references.pmid: 15122207
references.citation: Cancer Res. 1988 Jul 15;48(14):3910-8
references.pmid: 2454731
references.citation: J Neurooncol. 2007 May;83(1):53-60
references.pmid: 17245623
references.citation: Acta Neuropathol. 2005 Feb;109(2):207-10
references.pmid: 15791479
references.citation: Curr Opin Investig Drugs. 2007 Dec;8(12):1009-21
references.pmid: 18058572
references.citation: J Cancer Res Clin Oncol. 2006 Sep;132(9):589-99
references.pmid: 16736141
references.citation: Oncogene. 1992 Apr;7(4):627-33
references.pmid: 1314366
references.citation: Science. 2008 Sep 26;321(5897):1807-12
references.pmid: 18772396
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: Neurosurg Clin N Am. 2007 Jan;18(1):39-58, viii
references.pmid: 17244553
references.citation: Nature. 2001 May 17;411(6835):355-65
references.pmid: 11357143
references.citation: Lab Invest. 2007 Jan;87(1):75-83
references.pmid: 17170740
references.citation: Proc Natl Acad Sci U S A. 2005 Oct 4;102(40):14344-9
references.pmid: 16186508
references.citation: J Pathol. 2008 Dec;216(4):399-407
references.pmid: 18810758
references.citation: Am J Clin Pathol. 2005 Jun;123(6):900-6
references.pmid: 15899783
references.citation: Lab Invest. 2006 Apr;86(4):398-408
references.pmid: 16446704
references.citation: J Neurosurg. 2001 Aug;95(2):190-8
references.pmid: 11780887
references.citation: Neuron. 2006 Jul 20;51(2):187-99
references.pmid: 16846854
references.citation: J Neuropathol Exp Neurol. 2000 Jun;59(6):495-503
references.pmid: 10850862
references.citation: Curr Opin Oncol. 2007 Nov;19(6):598-605
references.pmid: 17906459
references.citation: Nat Rev Drug Discov. 2002 Jul;1(7):493-502
references.pmid: 12120256
references.citation: Breast Cancer Res. 2005;7(5):R788-95
references.pmid: 16168125
references.citation: Cell. 1988 Apr 22;53(2):309-19
references.pmid: 2834067
references.citation: J Clin Pathol. 2008 Feb;61(2):203-8
references.pmid: 17827398
references.citation: Brain Pathol. 2009 Jul;19(3):399-408
references.pmid: 18637011
references.citation: Int J Cancer. 1995 Jan 17;60(2):168-73
references.pmid: 7829210
references.citation: Pediatr Neurosurg. 1996;24(2):74-8
references.pmid: 8841077
references.citation: J Surg Oncol. 2004 Apr 1;86(1):34-40
references.pmid: 15048678
references.citation: Breast Cancer Res Treat. 2009 Dec;118(3):481-98
references.pmid: 19169812
references.citation: J Pathol. 2005 Oct;207(2):224-31
references.pmid: 16021678
references.citation: Cell Oncol. 2005;27(5-6):319-26
references.pmid: 16373964
references.citation: Neuro Oncol. 2007 Jul;9(3):291-7
references.pmid: 17504929
references.citation: N Engl J Med. 2001 Apr 5;344(14):1038-42
references.pmid: 11287973
references.citation: Bioinformatics. 2007 Sep 15;23(18):2463-9
references.pmid: 17660206
references.citation: Oncogene. 2006 Aug 10;25(35):4913-22
references.pmid: 16547494
references.citation: J Clin Oncol. 2008 Oct 1;26(28):4659-65
references.pmid: 18824712
references.citation: Clin Cancer Res. 2006 Aug 15;12(16):4899-907
references.pmid: 16914578
references.citation: Diagn Mol Pathol. 2005 Dec;14(4):224-9
references.pmid: 16319692
references.citation: N Engl J Med. 2008 Jul 31;359(5):492-507
references.pmid: 18669428
references.citation: Int J Cancer. 2004 Dec 20;112(6):1081-2
references.pmid: 15386438
references.citation: Proc Natl Acad Sci U S A. 1988 Oct;85(20):7748-52
references.pmid: 2845420
references.citation: Cancer Res. 1992 Jun 1;52(11):3213-9
references.pmid: 1317261
references.citation: Cancer Lett. 2006 Feb 8;232(2):139-47
references.pmid: 16139423
references.citation: J Clin Oncol. 2005 Dec 20;23(36):9359-68
references.pmid: 16361636
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: Mol Cancer Res. 2006 Dec;4(12):927-34
references.pmid: 17189383
references.citation: Nat Genet. 2008 Jul;40(7):809-10; author reply 810-2
references.pmid: 18583966
references.citation: Annu Rev Pathol. 2006;1:97-117
references.pmid: 18039109
references.citation: Lab Invest. 1992 Oct;67(4):529-34
references.pmid: 1434531
references.citation: Cell Oncol. 2007;29(5):399-408
references.pmid: 17726262
references.citation: Cancer Res. 1996 Jan 1;56(1):164-71
references.pmid: 8548759
references.citation: J Neurooncol. 2008 May;87(3):247-53
references.pmid: 18193393
references.citation: J Biol Chem. 1991 Sep 5;266(25):16755-63
references.pmid: 1653246
references.citation: N Engl J Med. 2002 Aug 15;347(7):472-80
references.pmid: 12181401
references.citation: Cancer Res. 1992 Aug 15;52(16):4550-3
references.pmid: 1322795
references.citation: Cancer Res. 2002 Jul 1;62(13):3729-35
references.pmid: 12097282